Amneal Pharmaceuticals ( NYSE:AMRX – Get Free Report ) issued an update on its FY 2023 earnings guidance on Friday morning. The company provided EPS guidance of $0.45-$0.55 for the period, compared to the consensus EPS estimate of $0.47. The company issued revenue guidance of $2.30 billion-$2.40 billion, compared to the consensus revenue estimate of $2.32 billion. Amneal Pharmaceuticals Price Performance AMRX traded up $0.75 during trading hours on Friday, hitting $4.11. The company's stock had a trading volume of 4,307,470 shares, compared to its average volume of 820,039.

https://www.dailypolitical.com/2023/08/05/amneal-pharmaceuticals-nyseamrx-issues-fy-2023-earnings-guidance.html

#dailypolitical